Page 2887 - Cote clinical veterinary advisor dogs and cats 4th

1534 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.

German shepherd (Continued) Giardiasis, 386–387, 386f, 387.e1f, 830.e6 Glucocorticoid(s) (Continued)
pemphigus erythematosus in, 769 Gingival hyperplasia, 712, 776 short-acting, 1510.e7t
protozoal enteritides, 830.e6
perianal adenocarcinoma in, 31
for snake envenomation, 924
VetBooks.ir perianal fistula in, 771 Gingivitis, 776, 1090, 1090.e1 Glucocorticoid deficiency. See Hypoadrenocorticism
for stomatitis, 944
juvenile hyperplastic, 943
pericardial effusion in, 773
phobias in, 787
Glucocorticoid hepatopathy. See Vacuolar hepatopathy
periodontal. See Periodontal disease
pituitary dwarfism in, 790.e2
protein-losing enteropathy in, 600 Gingivostomatitis. See Stomatitis Glucosamine-chondroitin sulfate
administration and dosage of, 1481
Ginkgo, 463t–464t
protothecosis in, 830.e4 Ginkyo, 463t–464t for osteoarthritis, 722
pseudocyesis in, 831 Ginseng, 463t–464t Glucosamine hydrochloride, for osteochondrosis, 724
pyoderma in, 851 GIST. See Gastrointestinal stromal tumor (GIST) Glucose, blood, 1348
rectal masses in, 865 Glargine insulin, 253. See also Insulin decreased. See Hypoglycemia
regurgitation in, 873 Glasgow Coma Score, modified, 406t increased. See Hyperglycemia
renal neoplasia in, 876 Glass. See Amphetamine toxicosis Glucose curve, 1119–1120
Rocky Mountain spotted fever in, 891 Glaucoma, 387–389, 389.e1f Glucose-6–phosphate dehydrogenase deficiency, 1335
salivary gland disorders in, 894 diagnostic approach to, 1419a Glucosuria, 1348–1349
sebaceous adenitis in, 901 red eye and, 870 causes of, 1227
seborrhea in, 214 secondary, 511–512 in Fanconi syndrome, 323
splenic hemangiosarcoma in, 2.e3 Glenohumeral ligament disruption, 914 Glucotrol. See Glipizide
splenic masses in, 629 Glenoid dysplasia, 913 Glue toxicosis, 32–33
splenic torsion in, 935 Glial tumors, spinal cord, 932 Glutamic pyruvate transaminase, serum (SGPT). See
splenomegaly in, 936 Glipizide, 1481 Alanine aminotransferase (ALT)
stunted growth in, 946 Globe Glutaraldehyde, 1217.e1
subaortic stenosis in, 948 enlargement of. See Buphthalmos Glycated hemoglobin, 1349
systemic lupus erythematosus in, 955 proptosis of, 823–824 Glycocalyx, 725
third eyelid disorders in, 970 Globoid cell leukodystrophy, 945.e2–945.e3 Glycogenosis type II, 945.e2–945.e3
thymoma in, 973 Globule cell neoplasm. See Gastrointestinal lymphoma Glycogenosis type IV, 945.e2–945.e3
ununited anconeal process in, 288 Globulin fractions, 1375 Glycol alcohol. See Ethylene glycol intoxication
urolithiasis in, 1014.e2 Globulins, serum, 1347–1348. See also Glycopyrrolate
vaginal hyperplasia/prolapse in, 1028 Hyperglobulinemia administration and dosage of, 1481
vascular ring anomaly in, 1031.e2 Glomerular disease for bradycardia, 65
vasculitis in, 1031.e4 in cats, 1226 Glycosaminoglycan, for lameness, 572
ventricular arrhythmia in, 1033 nephrotic syndrome and, 691 Glycosaminoglycan-polysulfated
vestibular disease in, 403 protein-losing nephropathy and, 830.e2–830.e4 administration and dosage of, 1481
von Willebrand disease in, 1043 Glomerulonephritis, 390–392, 1226, 1420a for osteoarthritis, 722
German short-haired pointer. See also Pointer Glossopharyngeal nerve for osteochondrosis, 724
acne in, 15 deficits of, 1210 for patellar luxation, 764
cutaneous lupus erythematosus in, 228 neurologic evaluation of, 1137 Glycosuria. See Glucosuria
footpad disorders in, 350 Glucagonoma, 383.e2–383.e3 Glycosylated hemoglobin. See Glycated hemoglobin
myasthenia gravis in, 668 Glucagonoma syndrome. See Superficial necrolytic Glyphosate herbicide toxicosis, 392–393
paraphimosis in, 756.e4 dermatitis GME. See Granulomatous meningoencephalitis (GME)
paroxysmal dyskinesia in, 661 Glucantime. See Meglumine antimonite GnRH. See Gonadotropin-releasing hormone (GnRH)
sensory polyneuropathies in, 808 Glucocerebrosidase deficiency, 945.e2–945.e3 Gold salts, for rheumatoid arthritis, 889
third eyelid disorders in, 970 Glucocorticoid(s). See also Corticosteroid(s); specific drugs Golden retriever
von Willebrand disease in, 1043 for acid or alkali (corrosives) toxicosis, 14 acral lick dermatitis in, 16
German wirehaired pointer, von Willebrand disease in, for acral lick dermatitis, 17 acral lick granuloma in, 589.e2
1043 for acute moist dermatitis, 26 acute leukemia in, 586
Gestation. See Pregnancy for adrenocortical neoplasia, 36 acute moist dermatitis in, 26
Gestation length, 816 allergy testing and, 92 atopic dermatitis in, 91
Gestational age, 280t for Baylisascaris infection, 114.e2 chondrosarcoma in, 165
GGT. See Gamma-glutamyltransferase (GGT) for bordetellosis, 126 dilated cardiomyopathy in, 960
GH. See Growth hormone (GH) for bronchiectasis, 133 distichiasis in, 273
Giant cell epulides, 307, 712 for canine distemper encephalitis, 272 dystrophin-deficient muscular dystrophy in, 676.e2
Giant cell granuloma, 307 for chronic hepatitis, in cocker spaniels, 451 ectopic ureter in, 282
Giant cell tumor, 307 comparisons of, 1510.e7 enteropathies in, 1221.e1t
Giant schnauzer for contact dermatitis, 204.e2 epilepsy in, 903
cobalamin deficiency in, 183 cortisol assay and, cross-reactivity between, 1329, 1361 eyelid masses in, 318
enteropathies in, 1221.e1t for cutaneous lupus erythematosus, 229 facial muscle wasting in, 320
intrinsic factor insufficiency in, 1325 for ehrlichiosis, 287 familial nephropathy in, 169
melanoma in, 644 for eosinophilic bronchopneumopathy, 299 glomerulonephritis in, 390
proliferative arteritis of the nasal philtrum in, for eosinophilic granuloma complex, 301 granulocytic anaplasmosis in, 393
1032 for esophageal stricture, 311 hemangiosarcoma in, 424
recurrent flank alopecia in, 869 for facial muscle wasting, 320 hip dysplasia in, 469
squamous cell carcinoma in, 939 for feline asthma, 85 histiocytic diseases in, 474
stunted growth in, 946 fetal adverse effects and, 818 Horner’s syndrome in, 481.e2
Giant–breed dogs. See also specific breeds for fever of unknown origin, 335 hypothyroidism in, 525
acral lick dermatitis in, 702 for head trauma, 406 ichthyosis in, 214
acute congestive heart failure in, 408 for hypercalcemia, 492 intracranial neoplasia in, 557
atrial fibrillation in, 94 for hypoadrenocorticism, 514 intraocular neoplasia in, 557
callus/pressure sore in, 143.e2 iatrogenic hypoadrenocorticism and, 513 iris abnormalities in, 563
chronic heart failure in, 410 intermediate-acting, 1510.e7t juvenile cellulitis in, 848
dilated cardiomyopathy in, 263 for interstitial lung disease, 554 Lyme nephritis in, 596
elbow hygroma in, 290 for intervertebral disc disease, 556 lymphoma in, 609
fibrocartilaginous embolism in, 336 long-acting, 1510.e7t malignant fibrous histiocytoma in, 616.e2
gastric dilation/volvulus in, 377 for lymphangiectasia, 601 mast cell tumor in, 634
hip dysplasia in, 469 for lymphoplasmacytic rhinitis, 891 melanoma in, 644, 644f
laryngeal paralysis in, 574 for masticatory myositis, 638 meningioma in, 932
lymphedema in, 602.e2 for neck pain, 684 mixed polyneuropathies in, 808
osteochondrosis in, 723 nonsteroidal antiinflammatory drugs and, for gastric myasthenia gravis in, 668
splenic masses in, 629 ulcer, 382 nephrotic syndrome in, 691
splenic torsion in, 935 for pemphigus complex, 770 nodular skin disorders in, 694
Giardia spp., 1347 for polyradiculoneuritis, 811 orbital diseases in, 716
G. duodenalis, 386–387, 386f, 387.e1f for protein-losing enteropathy, 601 osteochondrosis in, 723
G. intestinalis, 386 for pruritus, 831 osteogenesis imperfecta in, 724.e2
G. lamblia, 386, 830.e6 for rheumatoid arthritis, 889 paroxysmal dyskinesia in, 661
www.ExpertConsult.com